Shots: The US FDA has granted Emergency Use Authorization (EUA) for its rapid point-of-care BD Veritor SARS-CoV-2 Assay which allows the result in 15 mins evaluated in 20 sites across […]readmore
Tags : Point-of-care
Shots: Chembio to receive funding if reaches certain milestones, to develop POC test utilizing Chembio’s DPP platform and hand-held optical analyzer. The POC test will be built upon Takeda’s biomarker […]readmore
Shots: ChemBio will be using its patented DPP® technology platform to test rapid HCV core antigen assay Parallely, FIND is conducting pilot studies in six countries to introduce novel algorithms […]readmore